Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Why Signet Jewelers (SIG) stock is sliding as Pandora flags weak U.S. holiday demand

Why Signet Jewelers (SIG) stock is sliding as Pandora flags weak U.S. holiday demand

New York, Jan 9, 2026, 13:36 EST — Regular session Signet Jewelers Ltd shares fell 5.3% to $85.29 on Friday afternoon, after opening lower and sliding as far as $83.10. The stock last closed at $90.05. The move matters because Signet sits in the middle of the U.S. holiday gifting season — the stretch that can make or break the year for jewelry sellers. A sour read-through from overseas didn’t help, and investors are quick to price in any wobble in discretionary spending. Pandora rattled the space earlier on Friday when it cut its 2025 organic sales growth forecast to
9 January 2026
Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

NEW YORK, Jan 9, 2026, 13:43 EST — Regular session Qfin Holdings’ U.S.-listed shares slid on Friday, dropping about 4.5% to $17.32, even as the broader U.S. market pushed higher. The stock hit a session low of $17.21. Source The move matters because Qfin sits at the crossroads of two touchy stories right now: U.S.-China policy risk and the health of Chinese consumer credit. The company, formerly known as Qifu Technology, runs a credit-tech platform in China and trades in the U.S. as American depositary shares, a wrapper that lets overseas firms list on U.S. exchanges. Source Investors have been
Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

New York, Jan 9, 2026, 13:28 (EST) — Regular session Soleno Therapeutics shares slid on Friday, extending a choppy stretch for the rare-disease drugmaker. The stock was down 5.6% at $42.95, after touching a low of $42.73, while the SPDR S&P Biotech ETF was up about 1.1%. The move matters now because Soleno’s story still hinges on a young commercial launch and a single product, Vykat XR. Any shift in sentiment around safety, pricing, or patients staying on therapy can hit the stock hard, fast. A Zacks Equity Research industry outlook on Thursday highlighted Soleno alongside Nektar Therapeutics, Rigel Pharmaceuticals,
Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

New York, January 9, 2026, 13:20 (EST) — Regular session Wave Life Sciences Ltd shares fell about 5.6% on Friday, down 83 cents at $14.00, after trading between $13.99 and $15.09. The drop came even as biotech exchange-traded funds rose, with the SPDR S&P Biotech ETF up about 1% and the iShares Nasdaq Biotechnology ETF up about 0.5%. The move matters because Wave has become a high-beta obesity trade in the biotech tape, and the stock has been swinging on every new data point and funding headline. Traders have been leaning on near-term catalysts rather than fundamentals, and those catalysts
Reddit stock slides after Cantor starts coverage at Neutral and CFO sale hits filings

Reddit stock slides after Cantor starts coverage at Neutral and CFO sale hits filings

New York, Jan 9, 2026, 13:16 ET — Regular session Reddit, Inc shares fell 5.8% to $239.12 in afternoon trading on Friday, reversing an early push above $260. The move matters because Reddit stock has been priced like a fast grower, and fresh coverage is starting to draw harder lines around what that growth is worth. With results for the holiday quarter still ahead, even a “nothing’s broken” call can jolt a name trading at a premium. U.S. stocks were higher after a softer December jobs report, leaving Reddit as an outlier on the tape. The Nasdaq Composite was up
Oddity Tech stock drops nearly 6% after Oddity Labs science chief exit, KeyBanc trims target

Oddity Tech stock drops nearly 6% after Oddity Labs science chief exit, KeyBanc trims target

New York, Jan 9, 2026, 13:11 EST — Regular session Oddity Tech Ltd shares fell 5.8% to $36.28 on Friday, extending a sharp pullback for the beauty and wellness company as investors weighed a senior departure at its research unit and a fresh price-target cut. The stock opened higher but swung between $35.80 and $38.82. In a Form 6-K filing with U.S. regulators — a report foreign-listed companies use to disclose material updates — Oddity said Dr. Ido Bachelet is no longer employed with the company. Bachelet had served as chief science officer of ODDITY LABS, and his duties have
Under Armour stock drops 6% as BlackRock reveals 10.6% stake in UAA

Under Armour stock drops 6% as BlackRock reveals 10.6% stake in UAA

NEW YORK, Jan 9, 2026, 13:03 ET — Regular session Under Armour’s voting Class A shares (UAA) sank roughly 6% on Friday after a disclosure showed BlackRock owned more than a tenth of the sportswear maker. The stock was off 6.1% at $5.64 by midday, after moving in a range of $6.10 to $5.61. The timing is awkward for Under Armour. The company is in reset mode, and the stock has started getting jumpy again. Big ownership updates can squeeze the “tradable” float — shares that actually change hands day to day — and that can make price swings sharper.
Gold price today: 24K jumps to ₹137,122/10g, silver back above ₹242,000/kg after whipsaw

Gold price today: 24K jumps to ₹137,122/10g, silver back above ₹242,000/kg after whipsaw

NEW DELHI, January 9, 2026, 23:22 IST India’s benchmark gold and silver rates jumped on Friday, lifting bullion back toward recent highs after Thursday’s slide. The India Bullion and Jewellers Association (IBJA), an industry body that publishes benchmark bullion prices, put its PM rate for 24-carat gold (999 purity) at 137,122 rupees per 10 grams, up 1,349 rupees on the day, while silver (999) rose 6,982 rupees to 242,808 rupees per kg. IBJA rates are quoted before India’s goods and services tax (GST) and before jewellers add making charges. (ibjarates.com) The move matters because it keeps domestic prices pinned near
Almonty Industries stock drops after lock-up ends; traders look to March earnings date

Almonty Industries stock drops after lock-up ends; traders look to March earnings date

Toronto, January 9, 2026, 13:01 EST — Regular session Almonty Industries Inc shares fell 6.8% to C$12.01 in Toronto by around 1 p.m. EST, while the miner’s Nasdaq-listed stock was down 7.8% at $8.58. The stock has traded between C$12.01 and C$12.94 on the day, after closing at C$12.88 on Thursday. (Investing.com) The drop comes a day after a short “lock-up” expired, according to S&P Capital IQ data. A lock-up is an agreement that stops certain holders from selling shares for a set period after a stock sale, and the note said the restriction ran from Dec. 9 to Jan.
Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

New York, January 9, 2026, 13:01 EST — Regular session Immunome, Inc. shares jumped on Friday, outpacing a firmer biotech tape. The Nasdaq-listed stock (IMNM) was up 7.4% at $21.97, after trading between $20.71 and $22.00. The move keeps attention on Immunome’s lead drug, varegacestat, being developed for desmoid tumors — non-cancerous growths in connective tissue that can still be painful and hard to treat. The company has said it plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration in the second quarter of 2026; an NDA is the formal request for approval to
SoundHound AI stock jumps 9% as CES 2026 headlines collide with a fresh DA Davidson target cut

SoundHound AI stock jumps 9% as CES 2026 headlines collide with a fresh DA Davidson target cut

New York, Jan 9, 2026, 12:45 EST — Regular session Shares of SoundHound AI Inc (SOUN) were up about 9% at $12.01 in midday trading on Friday after hitting an intraday high of $12.305. The stock traded as low as $11.15, with about 27.5 million shares changing hands. The move follows a choppy stretch for the voice-AI company after brokerage D.A. Davidson cut its price target to $14 from $17 while keeping a “buy” rating, according to a Reuters Breakingviews “BUZZ” item. The broker said SoundHound’s go-to-market plans — its sales rollout — look more complex than expected, which could
Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

NEW YORK, Jan 9, 2026, 12:43 EST — Regular session Regencell Bioscience Holdings Limited shares rose about 8.5% to $44.96 in midday trading on Friday, clawing back from an early dip. The stock has swung between $35.13 and $50.92 in the session, with more than 1.1 million shares traded. The bounce keeps attention on RGC after a stretch of sharp moves that has been hard to pin on fresh company updates. Regencell’s investor-relations site shows its most recent press release was dated Oct. 31. (Regencell Bioscience –) Thursday was a reminder of how quickly the shares can turn: they ended
1 358 359 360 361 362 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop